Literature DB >> 33505472

Reestablishment of Redox Homeostasis in the Nociceptive Primary Afferent as a Mechanism of Antinociception Promoted by Mesenchymal Stem/Stromal Cells in Oxaliplatin-Induced Chronic Peripheral Neuropathy.

Anna Lethicia L Oliveira1, Gisele G L Santos1, Renan F Espirito-Santo1, Gessica Sabrina A Silva2, Afrânio F Evangelista1, Daniela N Silva3, Milena B P Soares1,3,4, Cristiane Flora Villarreal1,2.   

Abstract

Painful neuropathy is a common adverse effect of oxaliplatin (OXL), a platinum-derivative chemotherapeutic agent. Oxidative stress and mitochondrial dysfunction are key factors contributing to the development of OXL-induced peripheral neuropathy (OIPN). Based on the antioxidant and antinociceptive properties of mesenchymal stem/stromal cells (MSC), the present study tested the hypothesis that MSC induce antinociceptive effects during OIPN by promoting regulation of redox environment and mitochondrial homeostasis in the nociceptive primary afferents. C57Bl/6 mice submitted to the OXL-chronic neuropathy induction protocol by repeated intravenous administration of OXL (1 mg/kg) were evaluated to determine the paw mechanical and thermal nociceptive thresholds using the von Frey filaments and cold plate tests, respectively. Two weeks after the neuropathy induction, mice were treated with bone marrow-derived MSC (1 × 106), vehicle, or gabapentin (GBP, 70 mg/kg). Four weeks later, mitochondrial morphology, gene expression profile, and oxidative stress markers in the sciatic nerve and dorsal root ganglia (DRG) were evaluated by transmission electron microscopy, RT-qPCR, and biochemical assays, respectively. OXL-treated mice presented behavioral signs of sensory neuropathy, such as mechanical allodynia and thermal hyperalgesia. The behavioral painful neuropathy was completely reverted by a single administration of MSC, while the daily treatment with GBP induced only a short-lived antinociceptive effect. The ultrastructural analysis of the sciatic nerve and DRG of OIPN mice revealed a high proportion of atypical mitochondria in both myelinated and unmyelinated fibers. Importantly, this mitochondrial atypia was strongly reduced in MSC-treated neuropathic mice. Moreover, MSC-treated neuropathic mice showed upregulation of Sod and Nrf2 mRNA in the sciatic nerve and DRG. In line with this result, MSC reduced markers of nitrosative stress and lipid peroxidation in the sciatic nerve and DRG from OIPN mice. Our data suggest that the reestablishment of redox homeostasis in the nociceptive primary afferents is a mechanism by which MSC transplantation reverts the OXL-induced chronic painful neuropathy.
Copyright © 2021 Anna Lethicia L. Oliveira et al.

Entities:  

Year:  2021        PMID: 33505472      PMCID: PMC7808808          DOI: 10.1155/2021/8815206

Source DB:  PubMed          Journal:  Stem Cells Int            Impact factor:   5.443


  73 in total

1.  Human mesenchymal stem cells efficiently manage oxidative stress.

Authors:  Araceli Valle-Prieto; Paulette A Conget
Journal:  Stem Cells Dev       Date:  2010-08-18       Impact factor: 3.272

2.  Antinociceptive properties of Micrurus lemniscatus venom.

Authors:  Gisele Graça Leite dos Santos; Luciana Lyra Casais e Silva; Milena Botelho Pereira Soares; Cristiane Flora Villarreal
Journal:  Toxicon       Date:  2012-07-24       Impact factor: 3.033

3.  Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

Authors:  Susanna B Park; Cindy S-Y Lin; Arun V Krishnan; David Goldstein; Michael L Friedlander; Matthew C Kiernan
Journal:  Brain       Date:  2009-09-10       Impact factor: 13.501

4.  Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Front Integr Neurosci       Date:  2011-12-01

5.  The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.

Authors:  Maria Isabel Azevedo; Anamaria Falcão Pereira; Ricardo Braz Nogueira; Flávio Esmeraldo Rolim; Gerly A C Brito; Deysi Viviana T Wong; Roberto C P Lima-Júnior; Ronaldo de Albuquerque Ribeiro; Mariana Lima Vale
Journal:  Mol Pain       Date:  2013-10-23       Impact factor: 3.395

6.  Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin.

Authors:  Nabila Boukelmoune; Gabriel S Chiu; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Acta Neuropathol Commun       Date:  2018-12-12       Impact factor: 7.801

7.  Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery.

Authors:  Valentina A Babenko; Denis N Silachev; Vasily A Popkov; Ljubava D Zorova; Irina B Pevzner; Egor Y Plotnikov; Gennady T Sukhikh; Dmitry B Zorov
Journal:  Molecules       Date:  2018-03-19       Impact factor: 4.411

8.  The role of mesenchymal stem cells in chemotherapy-induced gonadotoxicity.

Authors:  Iman O Sherif; Dina Sabry; Azza Abdel-Aziz; Osama M Sarhan
Journal:  Stem Cell Res Ther       Date:  2018-07-18       Impact factor: 6.832

9.  A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy.

Authors:  Lauren E Ta; James D Schmelzer; Allan J Bieber; Charles L Loprinzi; Gary C Sieck; Jill D Brederson; Philip A Low; Anthony J Windebank
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

10.  Transfer of mitochondria from astrocytes to neurons after stroke.

Authors:  Kazuhide Hayakawa; Elga Esposito; Xiaohua Wang; Yasukazu Terasaki; Yi Liu; Changhong Xing; Xunming Ji; Eng H Lo
Journal:  Nature       Date:  2016-07-28       Impact factor: 49.962

View more
  2 in total

1.  Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants.

Authors:  Tharsini Navaratnarajah; Marlen Bellmann; Annette Seibt; Ruchika Anand; Özer Degistirici; Roland Meisel; Ertan Mayatepek; Andreas Reichert; Fabian Baertling; Felix Distelmaier
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

Review 2.  Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems.

Authors:  Xi Hu; Zhijie Jiang; Longyu Teng; Hongyu Yang; Dongsheng Hong; Dongsheng Zheng; Qingwei Zhao
Journal:  Front Mol Biosci       Date:  2021-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.